Leukocyte migration inhibition (LMI) by a specific antigen in human toxoplasmosis.
The diagnostic value of the leukocyte migration inhibition test was examined by comparing it to other specific laboratory methods i.e. complement fixation, indirect haemagglutination and skin test in 10 patients with acquired lymphoglandular toxoplasmosis. In the acute phase the serological tests gave more reliable results than did the LMI test. In subacute and chronic cases, however, there was a good correlation between dermal reactivity and LMI test. LMI is believed to represent a specific test for the detection of cellular hypersensitivity in human toxoplasmosis and so it can be used as a non-invasive method instead of dermal tests.
D000906:Antibodies / Q000032:analysis; D000941:Antigens / Q000276:immunology; D002464:Cell Migration Inhibition; D003168:Complement Fixation Tests; D006386:Hemagglutination Tests; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D012882:Skin Tests; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000276:immunology
D000906:Antibodies; D000941:Antigens